Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03621085 · ClinicalTrials.gov registry record · Phase 4
Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Ketamine
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 43
- Enrollment target
NCT03621085 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 43 participants.
The verdict
NCT03621085, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 43 participants
- Enrollment target
Study Summary
The purpose of this project is to test how ketamine, an analgesics currently employed in the pre-hospital setting by the US Army, alters the capacity to tolerate a hemorrhagic insult in humans.
Interventions
- OTHER Placebo
- DRUG Ketamine Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2021-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03621085
The ClinicalTrials.gov registry entry for NCT03621085 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03621085 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03621085 about?
NCT03621085 is a clinical study titled "Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Ketamine". The purpose of this project is to test how ketamine, an analgesics currently employed in the pre-hospital setting by the US Army, alters the capacity to tolerate a hemorrhagic insult in humans.
What is the current status of trial NCT03621085?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 43 participants. The study started on 2018-06-01. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT03621085?
The interventions under investigation include: Placebo (OTHER), Ketamine Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT03621085?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.